— Know what they know.
Not Investment Advice

HPHA.DE XETRA

Heidelberg Pharma AG
1W: -8.9% 1M: -5.2% 3M: -9.6% YTD: -18.7% 1Y: -48.4% 3Y: -32.1% 5Y: -65.6%
€2.35 ($2.62)
-0.01 (-0.42%)
 
Weekly Expected Move ±5.3%
€2 €2 €2 €2 €3
XETRA · Healthcare · Biotechnology · Tech Score Sell · Power 42 · €109.9M mcap · 10M float · 0.033% daily turnover

📊 Key Metrics

TTM
€7M
Revenue
+78.0% YoY
€-33M
Net Income
-42.0% YoY
€-25M
Free Cash Flow
+8.6% YoY
91.3%
Gross Margin
10.2%
Op. Margin
19.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-1539.9%
ROA-60.5%
ROIC68.8%

Valuation

P/E-3.4
P/B-7.7
EV/EBITDA-3.2

Leverage

Debt/Equity-0.00
Current Ratio5.29
Interest Cov.-10542.5x

Quality Scores

Piotroski F4/9
Altman Z-11.44
Beneish M27.54

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms